EE282 Incremental Net Monetary Benefit of Direct Oral Anticoagulants for the Prevention of Venous Thromboembolism after Total Knee or Hip Replacement: A Systematic Review and Meta-Analysis

Sk Veettil,J Harris,Ms Syeed,A Thakkinstian,U Chaikledkaew,Dm Witt,N Chaiyakunapruk

doi:10.1016/j.jval.2022.04.528

EE282 Incremental Net Monetary Benefit of Direct Oral Anticoagulants for the Prevention of Venous Thromboembolism after Total Knee or Hip Replacement: A Systematic Review and Meta-Analysis

Sk Veettil, J Harris + Show 5 more

Open Access

https://doi.org/10.1016/j.jval.2022.04.528

Copy DOI

Journal: Value in Health	Publication Date: Jun 25, 2022
License type: publisher-specific-oa

Affiliation: University of Utah, Mahidol University

#Benefit Of Direct Oral Anticoagulants #Direct Oral Anticoagulants + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Direct oral anticoagulants (DOACs) are now used to prevent venous thromboembolism (VTE) following total knee and hip replacements (TKR and THR). This meta-analysis was conducted to quantitatively pool the incremental net benefit (INB) of using DOACs for the prevention of VTE in a population undergoing TKR or THR surgeries.

Full Text